Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/03/17
End: 08/31/19
Due: 08/31/20
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 02/28/13
Due: 02/28/14
Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus Disease
Phase: N/A
Priority: Normal
Start: 09/16/20
End: 07/01/22
Due: 07/01/23
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 03/31/15
Due: 03/31/16